These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 30354719)

  • 1. Morning Home Blood Pressure and Cardiovascular Events in Japanese Hypertensive Patients.
    Kario K; Iwashita M; Okuda Y; Sugiyama M; Saito I; Kushiro T; Teramukai S; Shimada K
    Hypertension; 2018 Oct; 72(4):854-861. PubMed ID: 30354719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Home blood pressure and cardiovascular outcomes in patients during antihypertensive therapy: primary results of HONEST, a large-scale prospective, real-world observational study.
    Kario K; Saito I; Kushiro T; Teramukai S; Ishikawa Y; Mori Y; Kobayashi F; Shimada K
    Hypertension; 2014 Nov; 64(5):989-96. PubMed ID: 25156169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential Long-Term Benefit of Home Systolic Blood Pressure Below 125 mm Hg for Cardiovascular Risk Reduction: The J-HOP Study Extended.
    Kario K; Okawara Y; Kanegae H; Hoshide S
    Hypertension; 2024 Feb; 81(2):282-290. PubMed ID: 38073531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morning and Evening Home Blood Pressure and Risks of Incident Stroke and Coronary Artery Disease in the Japanese General Practice Population: The Japan Morning Surge-Home Blood Pressure Study.
    Hoshide S; Yano Y; Haimoto H; Yamagiwa K; Uchiba K; Nagasaka S; Matsui Y; Nakamura A; Fukutomi M; Eguchi K; Ishikawa J; Kario K;
    Hypertension; 2016 Jul; 68(1):54-61. PubMed ID: 27160200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) Intensive Blood Pressure Regimen in the United States: Projections From NHANES (National Health and Nutrition Examination Survey).
    Bress AP; Kramer H; Khatib R; Beddhu S; Cheung AK; Hess R; Bansal VK; Cao G; Yee J; Moran AE; Durazo-Arvizu R; Muntner P; Cooper RS
    Circulation; 2017 Apr; 135(17):1617-1628. PubMed ID: 28193605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systolic Blood Pressure Response in SPRINT (Systolic Blood Pressure Intervention Trial) and ACCORD (Action to Control Cardiovascular Risk in Diabetes): A Possible Explanation for Discordant Trial Results.
    Huang C; Dhruva SS; Coppi AC; Warner F; Li SX; Lin H; Nasir K; Krumholz HM
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29133522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nighttime Blood Pressure Measured by Home Blood Pressure Monitoring as an Independent Predictor of Cardiovascular Events in General Practice.
    Kario K; Kanegae H; Tomitani N; Okawara Y; Fujiwara T; Yano Y; Hoshide S
    Hypertension; 2019 Jun; 73(6):1240-1248. PubMed ID: 31006331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systolic Blood Pressure Intervention Trial (SPRINT) and Target Systolic Blood Pressure in Future Hypertension Guidelines.
    Egan BM; Li J; Wagner CS
    Hypertension; 2016 Aug; 68(2):318-23. PubMed ID: 27354422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generalizability of SPRINT Results to the U.S. Adult Population.
    Bress AP; Tanner RM; Hess R; Colantonio LD; Shimbo D; Muntner P
    J Am Coll Cardiol; 2016 Feb; 67(5):463-72. PubMed ID: 26562046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Intensive Systolic Blood Pressure Lowering on Cardiovascular Events and Mortality in Patients With Type 2 Diabetes Mellitus on Standard Glycemic Control and in Those Without Diabetes Mellitus: Reconciling Results From ACCORD BP and SPRINT.
    Beddhu S; Chertow GM; Greene T; Whelton PK; Ambrosius WT; Cheung AK; Cutler J; Fine L; Boucher R; Wei G; Zhang C; Kramer H; Bress AP; Kimmel PL; Oparil S; Lewis CE; Rahman M; Cushman WC
    J Am Heart Assoc; 2018 Sep; 7(18):e009326. PubMed ID: 30371182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BP Targets in Hypertension: What Should We Do Now That SPRINT Is Out?
    Bhatt H; Ghazi L; Calhoun D; Oparil S
    Curr Cardiol Rep; 2016 Oct; 18(10):98. PubMed ID: 27566331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Hypertension: Which Goal for Which Patient?
    Jarraya F
    Adv Exp Med Biol; 2017; 956():117-127. PubMed ID: 27722961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. J Curve in Patients Randomly Assigned to Different Systolic Blood Pressure Targets: An Experimental Approach to an Observational Paradigm.
    Kalkman DN; Brouwer TF; Vehmeijer JT; Berger WR; Knops RE; de Winter RJ; Peters RJ; van den Born BH
    Circulation; 2017 Dec; 136(23):2220-2229. PubMed ID: 28939617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Day-by-Day Variability of Home Blood Pressure and Incident Cardiovascular Disease in Clinical Practice: The J-HOP Study (Japan Morning Surge-Home Blood Pressure).
    Hoshide S; Yano Y; Mizuno H; Kanegae H; Kario K
    Hypertension; 2018 Jan; 71(1):177-184. PubMed ID: 29133364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of optimal on-treatment diastolic blood pressure range using automated measurements in subjects with cardiovascular disease-Analysis of a SPRINT trial subpopulation.
    Sobieraj P; Lewandowski J; Siński M; Gaciong Z
    J Clin Hypertens (Greenwich); 2019 Jul; 21(7):911-918. PubMed ID: 31169350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertension Control in Adults With Diabetes Mellitus and Recurrent Cardiovascular Events: Global Results From the Trial Evaluating Cardiovascular Outcomes With Sitagliptin.
    Navar AM; Gallup DS; Lokhnygina Y; Green JB; McGuire DK; Armstrong PW; Buse JB; Engel SS; Lachin JM; Standl E; Van de Werf F; Holman RR; Peterson ED;
    Hypertension; 2017 Nov; 70(5):907-914. PubMed ID: 28847886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On-Treatment Blood Pressure and Cardiovascular Outcomes in Older Adults With Isolated Systolic Hypertension.
    Yano Y; Rakugi H; Bakris GL; Lloyd-Jones DM; Oparil S; Saruta T; Shimada K; Matsuoka H; Imai Y; Ogihara T
    Hypertension; 2017 Feb; 69(2):220-227. PubMed ID: 28049699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low Diastolic Blood Pressure is Not Related to Risk of First Episode of Stroke in a High-Risk Population: A Secondary Analysis of SPRINT.
    Sobieraj P; Lewandowski J; Siński M; Symonides B; Gaciong Z
    J Am Heart Assoc; 2019 Feb; 8(4):e010811. PubMed ID: 30744452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Eligibility Criteria for the Systolic Blood Pressure Intervention Trial in US Adults Among Excluded Groups: Age <50 Years, Diabetes Mellitus, or a History of Stroke.
    Bress AP; Tanner RM; Hess R; Gidding SS; Colantonio LD; Shimbo D; Muntner P
    J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27405811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Lowering Diastolic Pressure in Patients With and Without Cardiovascular Disease: Analysis of the SPRINT (Systolic Blood Pressure Intervention Trial).
    Khan NA; Rabkin SW; Zhao Y; McAlister FA; Park JE; Guan M; Chan S; Humphries KH
    Hypertension; 2018 May; 71(5):840-847. PubMed ID: 29581214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.